Securities Class Actions – ClaimsFiler

Case Type: Securities Class Actions

On May 7, 2025, UnitedHealth Group Incorporated was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased publicly
traded UnitedHealth securities between December 3, 2024 and April 16, 2025, inclusive (the “Class Period”).

On May 5, 2025, West Pharmaceutical Services, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise acquired West common stock between February 16, 2023, and February 12, 2025, inclusive (the “Class Period”).

On May 2, 2025, Civitas Resources, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”).

On May 1, 2025, Open Lending Corporation was sued for violations of the federal securities laws in the United States District Court for the Western District of Texas on behalf of investors who purchased or otherwise acquired Open Lending securities between February 24, 2022 and March 31, 2025, inclusive (the “Class Period”).

On April 25, 2025, Napco Security Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or
otherwise acquired Napco securities between February 5, 2024, to February 3, 2025, inclusive (the “Class Period”).

On April 25, 2025, Avis Budget Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”).

On April 18, 2025, NET Power Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased or otherwise acquired Net Power
securities between June 9, 2023 and March 7, 2025, both dates inclusive (the “Class Period”).

Ibotta Inc (NYSE: IBTA)

On April 17, 2025, Ibotta, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased or otherwise acquired publicly traded Ibotta securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO” or “Offering”).

On April 16, 2025, Zenas BioPharma was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Zenas BioPharma securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (the “IPO” or “Offering”).

On April 11, 2025, Treace Medical Concepts, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired Treace Medical securities between May 8, 2023, and May 7, 2024, inclusive (the “Class Period”).

On April 11, 2025, BigBear.ai Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the “Class Period”).

On April 4, 2025, Viatris Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Pennsylvania on behalf of investors who purchased or otherwise acquired Viatris securities between August 8, 2024, to February 26, 2025, inclusive (the “Class Period”).

On April 4, 2025, Everus Construction Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Everus common stock between October 31, 2024 and February 11, 2025, inclusive (the “Class Period”), including investors who held MDU Resources Group, Inc. (“MDU Resources”) common stock as of October 21, 2024 and acquired Everus common stock issued in connection with the spinoff of Everus Construction (defined below) on or about October 31, 2024 (the “Spinoff”).

On April 4, 2025, Canopy Growth Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”).

On April 3, 2025, Cerevel Therapeutics Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations
of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

On April 2, 2025, Bakkt Holdings, Inc.  was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Bakkt securities between March 25, 2024 and March 17, 2025, inclusive (the “Class Period”).

On March 28, 2025, Solaris Energy Infrastructure, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Texas on behalf of investors who purchased or otherwise acquired Solaris securities between July 9, 2024 and March 17, 2025, inclusive (the “Class Period”).

On March 28, 2025, SoundHound AI, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired SoundHound securities between May 10, 2024 and March 3, 2025, both dates inclusive (the “Class Period”).

On March 27, 2025, Actinium Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Actinium securities between October 31, 2022, and August 2, 2024, inclusive (the “Class Period”).

On March 24, 2025, Ultra Clean Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Ultra Clean securities between May 6, 2024 to February 24, 2025, inclusive (the “Class Period”).

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK